T Stage and Pretreatment Standardized Uptake Values Predict Tumor Recurrence With 5-Fraction SABR in Early-Stage Non-Small Cell Lung Cancer

Hsu, E. J., Mendel, J. T., Ward, K. A., El-Ashmawy, M., Lee, M., Choy, H., Westover, K. D., Vo, D. T., Timmerman, R. D., Sher, D. J., & Iyengar, P. (2022). T Stage and Pretreatment Standardized Uptake Values Predict Tumor Recurrence With 5-Fraction SABR in Early-Stage Non-Small Cell Lung Cancer. Advances in Radiation Oncology, 7(5), 100995. https://doi.org/10.1016/j.adro.2022.100995
Authors:
Eric J Hsu
Jameson T Mendel
Kristin A Ward
Mariam El-Ashmawy
Minjae Lee
Hak Choy
Kenneth D Westover
Dat T Vo
Robert D Timmerman
David J Sher
Puneeth Iyengar
Affiliated Authors:
Mariam El-Ashmawy
Publication Type:
Article
Unique ID:
10.1016/j.adro.2022.100995
PMID:
Publication Date:
Data Source:
PubMed

Record Created: